A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT05119010 · TERMINATED
Trial details
- NCT number
- NCT05119010
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-24
- Primary completion
- 2024-05-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.